Optical Biopsy of Human Skin in Conjunction With Laser Treatment
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00540566 |
Recruitment Status
:
Completed
First Posted
: October 8, 2007
Last Update Posted
: February 10, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Malignant Melanoma Merkel Cell Carcinoma Basal Cell Carcinoma Squamous Cell Carcinoma Atypical Nevi Congenital Nevi Seborrheic Keratosis Paget's Disease Dermatofibroma Kaposi's Sarcoma Port Wine Stain Hemangioma Tattoos Scleroderma Burns | Device: Optical Biopsy imaging |
Study Type : | Observational |
Actual Enrollment : | 113 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Optical Biopsy of Human Skin in Conjunction With Laser Treatment |
Study Start Date : | June 1999 |
Actual Primary Completion Date : | June 2008 |
Actual Study Completion Date : | July 2008 |

Group/Cohort | Intervention/treatment |
---|---|
Optical Biopsy
Optical Biopsy imaging
|
Device: Optical Biopsy imaging
Optical Biopsy imaging
|
- normal skin [ Time Frame: 12 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Male or female age > 18 years
Exclusion Criteria:
- current participation in any other investigational drug evaluation
- inability to understand and carry out instructions

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00540566
United States, California | |
Beckman Laser Institute, Unversity of California Irvine | |
Irvine, California, United States, 92612 |
Principal Investigator: | John S Nelson, M.D,Ph.D | Beckman Laser Institue, University of California Irvine |
Responsible Party: | Beckman Laser Institute and Medical Center, J.S.Nelson, MD,PhD,Professor of Surgery and Biomedical Engineering, University of California, Irvine |
ClinicalTrials.gov Identifier: | NCT00540566 History of Changes |
Other Study ID Numbers: |
NIH-LAMPP-1996-200 |
First Posted: | October 8, 2007 Key Record Dates |
Last Update Posted: | February 10, 2017 |
Last Verified: | February 2017 |
Additional relevant MeSH terms:
Carcinoma Carcinoma, Squamous Cell Keratosis Melanoma Carcinoma, Basal Cell Sarcoma, Kaposi Hemangioma Nevus Carcinoma, Merkel Cell Port-Wine Stain Hemangioma, Capillary Keratosis, Seborrheic Histiocytoma, Benign Fibrous Histiocytoma Neoplasms, Glandular and Epithelial |
Neoplasms by Histologic Type Neoplasms Neoplasms, Squamous Cell Skin Diseases Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Nevi and Melanomas Neoplasms, Basal Cell Herpesviridae Infections DNA Virus Infections Virus Diseases Sarcoma Neoplasms, Connective and Soft Tissue |